Axxcess Wealth Management, LLC Spero Therapeutics, Inc. Transaction History
Axxcess Wealth Management, LLC
- $4.06 Billion
- Q2 2025
A detailed history of Axxcess Wealth Management, LLC transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Axxcess Wealth Management, LLC holds 32,548 shares of SPRO stock, worth $72,582. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,548Holding current value
$72,582% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SPRO
# of Institutions
44Shares Held
14.4MCall Options Held
9.3KPut Options Held
100-
Anson Funds Management LP Dallas, TX3.8MShares$8.47 Million0.65% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.76MShares$3.93 Million0.0% of portfolio
-
Atlas Venture Associates Ix, LLC Boston, MA1.35MShares$3.02 Million14.54% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny971KShares$2.17 Million0.0% of portfolio
-
Alphabet Inc. Mountain View, CA890KShares$1.98 Million0.06% of portfolio
About Spero Therapeutics, Inc.
- Ticker SPRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,067,500
- Market Cap $78.2M
- Description
- Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...